mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.04 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.04 |